Fagron’s strategy is focused on the optimization and innovation of pharmaceutical compounding. As an R&D scientific pharmaceutical compounding company, Fagron wants to widen the therapeutic scope of the prescriber to enable tailor-made pharmaceutical care. Through its activities, Fagron supports the unique selling point of the pharmacist and improves the patient's quality of life. Fagron products are sold to 200,000 customers in over 60 countries around the world. Over 200 Fagron pharmacists are continually developing new, unique products and concepts to meet the growing worldwide need for tailor-made medication. Pharmacists and scientists from Fagron’s research and development team are continuously advancing knowledge through scientific studies, which are frequently published in renowned scientific journals.